PHB1 and colorectal carcinoma: Our study demonstrates a key mechanism of DIRAS1 in chemotherapy resistance of CRC and proposes a novel molecular pathway that promotes tumor cell resistance by regulating PHB1 to maintain mitochondrial homeostasis, which provides new theoretical basis and potential clinical strategies for targeted drug resistance.